Skip to main content
Erschienen in: Clinical Rheumatology 4/2005

01.08.2005 | Original Article

Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet’s disease: a pilot study

verfasst von: Fuat Duygulu, Cem Evereklioglu, Mustafa Calis, Murat Borlu, Mustafa Çekmen, Ozcan Ascioglu

Erschienen in: Clinical Rheumatology | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

Behçet’s disease (BD) is a relapsing immunoinflammatory vasculitis of unknown etiology characterized by endothelial dysfunction. Articular symptoms and signs are present in about 75% of cases and characterized by seronegative arthritis and nonspecific synovitis. We demonstrated that both serum and erythrocyte nitric oxide (NO·) levels, the most abundant free radical in the body, were elevated in BD and associated with disease activity. This study further investigated NO· levels in the synovial fluid and serum from patients with active and inactive BD. A total of 23 BD patients with articular involvement (14 men and 9 women) satisfying International Study Group criteria and 15 age- and sex-matched healthy control subjects (9 men and 6 women) undergoing elective arthroscopy were included in this case-control investigation. The synovial fluid and serum were obtained from BD patients and controls. Clinical and laboratory findings including neutrophil count and erythrocyte sedimentation rate (ESR) were used to classify BD patients as active (n=11) or inactive (n=12). Synovial as well as serum NO· levels were compared between the groups and correlation analysis was performed. Acute phase reactant levels were significantly higher (for each, p<0.01) in BD patients than control subjects in the active period. The mean synovial NO· level in active Behçet’s patients (mean±SD 76.61±11.95 μmol/l) was significantly higher than in inactive patients (46.16±8.89 μmol/l, p<0.001) and healthy control subjects (39.60±8.03 μmol/l, p<0.001). The difference between inactive patients and controls was not significant (p>0.05). Active BD patients had significantly higher serum NO· levels (38.84±9.15 μmol/l) than inactive patients (30.91±5.88 μmol/l, p=0.018) and control subjects (28.86±5.91 μmol/l, p=0.002). In addition, synovial NO· levels were positively correlated with serum levels (r2=0.621, p<0.001). Increased synovial NO· levels in active BD patients probably reflect a nonspecific inflammatory process of the synovium and, therefore, arthralgia and arthritis as a common finding of BD.
Literatur
1.
Zurück zum Zitat Behçet H (1937) Considerations sur les lesions aphtheuses de la bouche et des parties genitales, ainsi que sur les manifestations oculaires d’origine probablement virutique et observations concernant leur foyer d’infection. Bull Soc Fr Dermatol Syph 45:420–433 Behçet H (1937) Considerations sur les lesions aphtheuses de la bouche et des parties genitales, ainsi que sur les manifestations oculaires d’origine probablement virutique et observations concernant leur foyer d’infection. Bull Soc Fr Dermatol Syph 45:420–433
2.
Zurück zum Zitat Behçet H (1937) Über rezidivierende Aphthose, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152–1157 Behçet H (1937) Über rezidivierende Aphthose, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152–1157
3.
Zurück zum Zitat Önder M, Gürer MA (2000) The multiple faces of Behçet’s disease and its aetiological factors. J Eur Acad Dermatol Venereol 15:126–136CrossRefPubMed Önder M, Gürer MA (2000) The multiple faces of Behçet’s disease and its aetiological factors. J Eur Acad Dermatol Venereol 15:126–136CrossRefPubMed
4.
Zurück zum Zitat Türköz Y, Evereklioglu C, Mehmet N, Çekmen M, Er H (2000) Plasma malondialdehyde levels in Behçet’s disease with or without ocular involvement. Adv Reprod 4:31–36 Türköz Y, Evereklioglu C, Mehmet N, Çekmen M, Er H (2000) Plasma malondialdehyde levels in Behçet’s disease with or without ocular involvement. Adv Reprod 4:31–36
5.
Zurück zum Zitat Günen H, Evereklioglu C, Koşar F, Er H, Kizkin O (2000) Thoracic involvement in Behçet’s disease and its correlation with multiple parameters. Lung 178:161–170CrossRefPubMed Günen H, Evereklioglu C, Koşar F, Er H, Kizkin O (2000) Thoracic involvement in Behçet’s disease and its correlation with multiple parameters. Lung 178:161–170CrossRefPubMed
6.
Zurück zum Zitat Evereklioglu C, Özbek E, Er H, Çekmen M, Yürekli M (2002) Urinary adrenomedullin levels are increased and correlated with plasma concentrations in patients with Behçet’s syndrome. Int J Urol 9:296–303CrossRefPubMed Evereklioglu C, Özbek E, Er H, Çekmen M, Yürekli M (2002) Urinary adrenomedullin levels are increased and correlated with plasma concentrations in patients with Behçet’s syndrome. Int J Urol 9:296–303CrossRefPubMed
7.
Zurück zum Zitat Evereklioglu C, Özbek E, Çekmen M et al (2003) Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behçet’s disease: is it a new urinary activity marker? Nephrology 8:246–253CrossRef Evereklioglu C, Özbek E, Çekmen M et al (2003) Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behçet’s disease: is it a new urinary activity marker? Nephrology 8:246–253CrossRef
8.
Zurück zum Zitat Evereklioglu C, Çokkeser Y, Doganay S, Er H, Kizilay A (2001) Audio-vestibular evaluation in patients with Behçet’s disease. J Laryngol Otol 115:704–708CrossRefPubMed Evereklioglu C, Çokkeser Y, Doganay S, Er H, Kizilay A (2001) Audio-vestibular evaluation in patients with Behçet’s disease. J Laryngol Otol 115:704–708CrossRefPubMed
9.
Zurück zum Zitat Evereklioglu C, Er H (2002) Increased corneal thickness in active Behçet’s disease. Eur J Ophthalmol 12:24–29PubMed Evereklioglu C, Er H (2002) Increased corneal thickness in active Behçet’s disease. Eur J Ophthalmol 12:24–29PubMed
10.
Zurück zum Zitat Karlidag R, Ünal S, Evereklioglu C et al (2003) Stressful life events, anxiety, depression and coping mechanisms in patients with Behçet’s disease. J Eur Acad Dermatol Venereol 17:670–675CrossRefPubMed Karlidag R, Ünal S, Evereklioglu C et al (2003) Stressful life events, anxiety, depression and coping mechanisms in patients with Behçet’s disease. J Eur Acad Dermatol Venereol 17:670–675CrossRefPubMed
11.
Zurück zum Zitat Evereklioglu C, Yürekli M, Er H et al (2000) Increased plasma adrenomedullin levels in patients with Behçet’s disease. Dermatology 201:312–315CrossRefPubMed Evereklioglu C, Yürekli M, Er H et al (2000) Increased plasma adrenomedullin levels in patients with Behçet’s disease. Dermatology 201:312–315CrossRefPubMed
12.
Zurück zum Zitat Evereklioglu C, Inalöz HS, Kirtak N et al (2002) Serum leptin concentration is increased in patients with Behçet’s syndrome and correlated with disease activity. Br J Dermatol 147:331–336CrossRefPubMed Evereklioglu C, Inalöz HS, Kirtak N et al (2002) Serum leptin concentration is increased in patients with Behçet’s syndrome and correlated with disease activity. Br J Dermatol 147:331–336CrossRefPubMed
13.
Zurück zum Zitat Behçet’s Disease Research Committee of Japan (1974) Behçet’s disease: guide to diagnosis of Behçet’s disease. Jpn J Ophthalmol 18:291–294 Behçet’s Disease Research Committee of Japan (1974) Behçet’s disease: guide to diagnosis of Behçet’s disease. Jpn J Ophthalmol 18:291–294
14.
Zurück zum Zitat Ghate JV, Jorizzo JL (1999) Continuing medical education. J Am Acad Dermatol 40:1–18PubMed Ghate JV, Jorizzo JL (1999) Continuing medical education. J Am Acad Dermatol 40:1–18PubMed
15.
Zurück zum Zitat Kim HA, Choi KW, Song YW (1997) Arthropathy in Behçet’s disease. Scand J Rheumatol 26:125–129PubMed Kim HA, Choi KW, Song YW (1997) Arthropathy in Behçet’s disease. Scand J Rheumatol 26:125–129PubMed
16.
Zurück zum Zitat Mazzetti I, Grigolo B, Pulsatelli L et al (2001) Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci 101:593–599CrossRefPubMed Mazzetti I, Grigolo B, Pulsatelli L et al (2001) Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci 101:593–599CrossRefPubMed
17.
Zurück zum Zitat Evereklioglu C, Türköz Y, Er H, Inalöz HS, Özbek E, Çekmen M (2002) Increased nitric oxide production in patients with Behçet’s disease: is it a new activity marker? J Am Acad Dermatol 46:50–54CrossRefPubMed Evereklioglu C, Türköz Y, Er H, Inalöz HS, Özbek E, Çekmen M (2002) Increased nitric oxide production in patients with Behçet’s disease: is it a new activity marker? J Am Acad Dermatol 46:50–54CrossRefPubMed
18.
Zurück zum Zitat Evereklioglu C, Çekmen M, Özkiriş A, Karabaş L, Çaliş M (2003) The pathophysiological significance of red blood cell nitric oxide concentrations in inflammatory Behçet’s disease. Mediators Inflamm 12:255–256CrossRefPubMed Evereklioglu C, Çekmen M, Özkiriş A, Karabaş L, Çaliş M (2003) The pathophysiological significance of red blood cell nitric oxide concentrations in inflammatory Behçet’s disease. Mediators Inflamm 12:255–256CrossRefPubMed
19.
Zurück zum Zitat Evereklioglu C, Er H, Türköz Y, Çekmen M (2002) Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet’s disease. Mediators Inflamm 11:87–93CrossRefPubMed Evereklioglu C, Er H, Türköz Y, Çekmen M (2002) Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet’s disease. Mediators Inflamm 11:87–93CrossRefPubMed
20.
Zurück zum Zitat Erkiliç K, Evereklioglu C, Çekmen M, Özkiriş A, Duygulu F, Dogan H (2003) Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet’s disease: original contributions/clinical and laboratory investigations. Mediators Inflamm 12:107–116CrossRefPubMed Erkiliç K, Evereklioglu C, Çekmen M, Özkiriş A, Duygulu F, Dogan H (2003) Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet’s disease: original contributions/clinical and laboratory investigations. Mediators Inflamm 12:107–116CrossRefPubMed
21.
Zurück zum Zitat Kiraz S, Ertenli I, Çalgüneri M et al (2001) Interactions of nitric oxide and superoxide dismutase in Behçet’s disease. Clin Exp Rheumatol 19:25–29 Kiraz S, Ertenli I, Çalgüneri M et al (2001) Interactions of nitric oxide and superoxide dismutase in Behçet’s disease. Clin Exp Rheumatol 19:25–29
22.
Zurück zum Zitat Er H, Evereklioglu C, Cumurcu T et al (2002) Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet’s disease. Br J Ophthalmol 86:653–657CrossRefPubMed Er H, Evereklioglu C, Cumurcu T et al (2002) Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet’s disease. Br J Ophthalmol 86:653–657CrossRefPubMed
23.
Zurück zum Zitat Atalay G, Ekşioglu-Demiralp E, Akoglu T, Direskeneli H (2002) The effects of nitric oxide donors and inhibitors on neutrophil functions in Behçet’s disease. Clin Exp Rheumatol 20:17–20 Atalay G, Ekşioglu-Demiralp E, Akoglu T, Direskeneli H (2002) The effects of nitric oxide donors and inhibitors on neutrophil functions in Behçet’s disease. Clin Exp Rheumatol 20:17–20
24.
Zurück zum Zitat Sancak B, Önder M, Öztaş MO, Bukan N, Gürer MA (2003) Nitric oxide levels in Behçet’s disease. J Eur Acad Dermatol Venereol 17:7–9CrossRefPubMed Sancak B, Önder M, Öztaş MO, Bukan N, Gürer MA (2003) Nitric oxide levels in Behçet’s disease. J Eur Acad Dermatol Venereol 17:7–9CrossRefPubMed
25.
Zurück zum Zitat Yilmaz G, Sizmaz S, Yilmaz ED, Duman S, Aydin P (2002) Aqueous humor nitric oxide levels in patients with Behçet disease. Retina 22:330–335CrossRefPubMed Yilmaz G, Sizmaz S, Yilmaz ED, Duman S, Aydin P (2002) Aqueous humor nitric oxide levels in patients with Behçet disease. Retina 22:330–335CrossRefPubMed
26.
Zurück zum Zitat Salvarani C, Boiardi L, Casali B et al (2002) Endothelial nitric oxide synthase gene polymorphisms in Behçet’s disease. J Rheumatol 29:535–540PubMed Salvarani C, Boiardi L, Casali B et al (2002) Endothelial nitric oxide synthase gene polymorphisms in Behçet’s disease. J Rheumatol 29:535–540PubMed
27.
Zurück zum Zitat Kim JU, Chang HK, Lee SS et al (2003) Endothelial nitric oxide gene polymorphisms in Behçet’s disease and rheumatic diseases with vasculitis. Ann Rheum Dis 62:1083–1087CrossRefPubMed Kim JU, Chang HK, Lee SS et al (2003) Endothelial nitric oxide gene polymorphisms in Behçet’s disease and rheumatic diseases with vasculitis. Ann Rheum Dis 62:1083–1087CrossRefPubMed
28.
Zurück zum Zitat International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080PubMed International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080PubMed
29.
Zurück zum Zitat Haklar U, Yüksel M, Velioglu A, Türkmen M, Haklar G, Yalçin AS (2002) Oxygen radicals and nitric oxide levels in chondral or meniscal lesions or both. Clin Orthop 403:135–142PubMed Haklar U, Yüksel M, Velioglu A, Türkmen M, Haklar G, Yalçin AS (2002) Oxygen radicals and nitric oxide levels in chondral or meniscal lesions or both. Clin Orthop 403:135–142PubMed
30.
Zurück zum Zitat Karan A, Karan MA, Vural P et al (2003) Synovial fluid nitric oxide levels in patients with knee osteoarthritis. Clin Rheumatol 22:397–399CrossRefPubMed Karan A, Karan MA, Vural P et al (2003) Synovial fluid nitric oxide levels in patients with knee osteoarthritis. Clin Rheumatol 22:397–399CrossRefPubMed
31.
Zurück zum Zitat Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr (1996) Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol 268:142–151PubMed Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr (1996) Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol 268:142–151PubMed
32.
Zurück zum Zitat Doganay S, Evereklioglu C, Türköz Y, Er H (2002) Decreased nitric oxide production in primary open-angle glaucoma. Eur J Ophthalmol 12:44–48PubMed Doganay S, Evereklioglu C, Türköz Y, Er H (2002) Decreased nitric oxide production in primary open-angle glaucoma. Eur J Ophthalmol 12:44–48PubMed
33.
Zurück zum Zitat Evereklioglu C, Er H, Doganay S et al (2003) Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc Ophthalmol 106:129–136CrossRefPubMed Evereklioglu C, Er H, Doganay S et al (2003) Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc Ophthalmol 106:129–136CrossRefPubMed
34.
Zurück zum Zitat Inalöz HS, Evereklioglu C, Ünal B, Kirtak N, Eralp A, Inalöz SS (2004) The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet’s syndrome. J Eur Acad Dermatol Venereol 18:56–61CrossRefPubMed Inalöz HS, Evereklioglu C, Ünal B, Kirtak N, Eralp A, Inalöz SS (2004) The significance of immunohistochemistry in the skin pathergy reaction of patients with Behçet’s syndrome. J Eur Acad Dermatol Venereol 18:56–61CrossRefPubMed
35.
Zurück zum Zitat Park JH (1999) Clinical analysis of Behçet disease: arthritic manifestations in Behçet disease may present as seronegative rheumatoid arthritis or palindromic rheumatism. Korean J Intern Med 14:66–72PubMed Park JH (1999) Clinical analysis of Behçet disease: arthritic manifestations in Behçet disease may present as seronegative rheumatoid arthritis or palindromic rheumatism. Korean J Intern Med 14:66–72PubMed
36.
Zurück zum Zitat Dilşen N, Koniçe M, Aral O (1986) Why Behçet’s disease should be accepted as a seronegative arthritis. In: Lehner T, Barnes CG (eds) Recent advances in Behçet’s disease. International Congress and symposium series, No.: 103. Royal Society of Medicine Services, London, pp 281–284 Dilşen N, Koniçe M, Aral O (1986) Why Behçet’s disease should be accepted as a seronegative arthritis. In: Lehner T, Barnes CG (eds) Recent advances in Behçet’s disease. International Congress and symposium series, No.: 103. Royal Society of Medicine Services, London, pp 281–284
37.
Zurück zum Zitat Hamza M, Hubault A, Ryckewaert A (1985) Les manifestations articulaires de la maladie de Behçet. Rev Rhum Mal Osteoartic 52:103–108PubMed Hamza M, Hubault A, Ryckewaert A (1985) Les manifestations articulaires de la maladie de Behçet. Rev Rhum Mal Osteoartic 52:103–108PubMed
38.
Zurück zum Zitat Caporn N, Higgs ER, Dieppe PA (1983) Arthritis in Behçet’s syndrome. Br J Radiol 56:87–90PubMed Caporn N, Higgs ER, Dieppe PA (1983) Arthritis in Behçet’s syndrome. Br J Radiol 56:87–90PubMed
39.
Zurück zum Zitat Çalgüneri M, Kiraz S, Ertenli I, Erman M, Karaaslan Y, Çelik I (1997) Characteristics of peripheral arthritis in Behçet’s disease. N Z Med J 110:80–81PubMed Çalgüneri M, Kiraz S, Ertenli I, Erman M, Karaaslan Y, Çelik I (1997) Characteristics of peripheral arthritis in Behçet’s disease. N Z Med J 110:80–81PubMed
40.
Zurück zum Zitat Ertenli I, Kiraz S, Çalgüneri M et al (2001) Synovial fluid cytokine levels in Behçet’s disease. Clin Exp Rheumatol 19:37–41 Ertenli I, Kiraz S, Çalgüneri M et al (2001) Synovial fluid cytokine levels in Behçet’s disease. Clin Exp Rheumatol 19:37–41
41.
Zurück zum Zitat Pickering MC, Haskard DO (2000) Behçet’s syndrome. J R Coll Physicians Lond 34:169–177PubMed Pickering MC, Haskard DO (2000) Behçet’s syndrome. J R Coll Physicians Lond 34:169–177PubMed
42.
Zurück zum Zitat Yurdakul S, Mat C, Tüzün Y et al (2001) A double-blind trial of colchicine in Behçet’s syndrome. Arthritis Rheum 44:2686–2692CrossRefPubMed Yurdakul S, Mat C, Tüzün Y et al (2001) A double-blind trial of colchicine in Behçet’s syndrome. Arthritis Rheum 44:2686–2692CrossRefPubMed
43.
Zurück zum Zitat Evereklioglu C (2004) Managing the symptoms of Behçet’s disease. Expert Opin Pharmacother 5:317–328CrossRefPubMed Evereklioglu C (2004) Managing the symptoms of Behçet’s disease. Expert Opin Pharmacother 5:317–328CrossRefPubMed
44.
Zurück zum Zitat Sakurai H, Kohsaka H, Liu MF et al (1995) Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 96:2357–2363PubMed Sakurai H, Kohsaka H, Liu MF et al (1995) Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 96:2357–2363PubMed
45.
Zurück zum Zitat Farrell AJ, Blake DR, Palmer RM, Moncada S (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51:1219–1222PubMed Farrell AJ, Blake DR, Palmer RM, Moncada S (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51:1219–1222PubMed
46.
Zurück zum Zitat McInnes IB, Leung BP, Field M et al (1996) Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184:1519–1524CrossRefPubMed McInnes IB, Leung BP, Field M et al (1996) Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184:1519–1524CrossRefPubMed
47.
Zurück zum Zitat Ueki Y, Miyake S, Tominaga Y, Eguchi K (1996) Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 23:230–236PubMed Ueki Y, Miyake S, Tominaga Y, Eguchi K (1996) Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 23:230–236PubMed
48.
Zurück zum Zitat Salvatierra J, Escames G, Hernandez P et al (1999) Cartilage and serum levels of nitric oxide in patients with hip osteoarthritis. J Rheumatol 26:2015–2017PubMed Salvatierra J, Escames G, Hernandez P et al (1999) Cartilage and serum levels of nitric oxide in patients with hip osteoarthritis. J Rheumatol 26:2015–2017PubMed
49.
Zurück zum Zitat Takahashi T, Kondoh T, Kamei K (1996) Elevated levels of nitric oxide in synovial fluid from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82:505–509PubMed Takahashi T, Kondoh T, Kamei K (1996) Elevated levels of nitric oxide in synovial fluid from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82:505–509PubMed
50.
Zurück zum Zitat Stefanovic-Racic M, Meyers M, Meschter C, Coffey CW, Hoffman RA, Evans CH (1994) N-Monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 37:1062–1069PubMed Stefanovic-Racic M, Meyers M, Meschter C, Coffey CW, Hoffman RA, Evans CH (1994) N-Monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 37:1062–1069PubMed
51.
Zurück zum Zitat Weinberg JB (1998) Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice. Environ Health Perspect 106:1131–1137PubMed Weinberg JB (1998) Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice. Environ Health Perspect 106:1131–1137PubMed
52.
Zurück zum Zitat Murrell GA, Doland MM, Jang D, Szabo C, Warren RF, Hannafin JA (1996) Nitric oxide: an important articular free radical. J Bone Joint Surg Am 78:265–274PubMed Murrell GA, Doland MM, Jang D, Szabo C, Warren RF, Hannafin JA (1996) Nitric oxide: an important articular free radical. J Bone Joint Surg Am 78:265–274PubMed
53.
Zurück zum Zitat Amin AR, Abramson SB (1998) The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr Opin Rheumatol 10:263–268PubMed Amin AR, Abramson SB (1998) The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr Opin Rheumatol 10:263–268PubMed
54.
Zurück zum Zitat Lotz M (1999) The role of nitric oxide in articular cartilage damage. Rheum Dis Clin North Am 25:269–282PubMed Lotz M (1999) The role of nitric oxide in articular cartilage damage. Rheum Dis Clin North Am 25:269–282PubMed
55.
Zurück zum Zitat Suenaga S, Abeyama M, Hamasaki A, Mimura T, Noikura T (2001) Temporomandibular disorders: relationship between joint pain and effusion and nitric oxide concentration in the joint fluid. Dentomaxillofac Radiol 30:214–218CrossRefPubMed Suenaga S, Abeyama M, Hamasaki A, Mimura T, Noikura T (2001) Temporomandibular disorders: relationship between joint pain and effusion and nitric oxide concentration in the joint fluid. Dentomaxillofac Radiol 30:214–218CrossRefPubMed
56.
Zurück zum Zitat Stichtenoth DO, Frolich JC (1998) Nitric oxide and inflammatory joint diseases. Br J Rheumatol 37:246–257CrossRefPubMed Stichtenoth DO, Frolich JC (1998) Nitric oxide and inflammatory joint diseases. Br J Rheumatol 37:246–257CrossRefPubMed
57.
Zurück zum Zitat Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial cell injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620–1624PubMed Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial cell injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620–1624PubMed
Metadaten
Titel
Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet’s disease: a pilot study
verfasst von
Fuat Duygulu
Cem Evereklioglu
Mustafa Calis
Murat Borlu
Mustafa Çekmen
Ozcan Ascioglu
Publikationsdatum
01.08.2005
Erschienen in
Clinical Rheumatology / Ausgabe 4/2005
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-1015-3

Weitere Artikel der Ausgabe 4/2005

Clinical Rheumatology 4/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.